Comparative Effectiveness of Angiotensin Receptor Blockers vs. Angiotensin-Converting Enzyme Inhibitors on Cardiovascular Outcomes in Patients Initiating Peritoneal Dialysis

BACKGROUND: There is evidence that angiotensin-converting enzyme inhibitors (ACEI) and angiotensin-II receptor blockers (ARB) may reduce cardiovascular (CV) risk in patients undergoing peritoneal dialysis (PD), but no studies have compared the effectiveness between these drug classes. In this observ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Nephrol
Main Authors: Shen, Jenny I., Saxena, Anjali B., Montez-Rath, Maria E., Leng, Lynn, Chang, Tara I., Winkelmayer, Wolfgang C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5446246/
https://ncbi.nlm.nih.gov/pubmed/27485007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40620-016-0340-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados